Levels of NMNAT2 mRNA are lower in the brain in AD patients and mouse AD models, and overexpression of NMNAT2 in cells that produce excess amyloid precursor protein (APP) suppresses amyloid formation by increasing the NAD+/NADH ratio [46]. Here, APP is linked to Alzheimer disease.